Thiel-backed Lindus pivots to hunting external drug assets after CRO-arm sale
Lindus Health, backed by Peter Thiel, sells its CRO division and pivots to in-licensing external pharmaceutical assets.
Lindus Health
Private
Lindus Health is a Thiel-backed company that has pivoted from a CRO arm to hunting for external drug assets. The company sold its contract research organization division to focus on in-licensing and developing pharmaceutical assets.